An HIV-infected patient treated with tenofovir disoproxil fumarate/emtricitabine/elvitegravir/cobicistat developed severe acute ischaemia of both legs during a migraine episode. After being interrogated he admitted taking an ergotamine-containing preparation. Ergotism due to interaction between ergotics and cobicistat was diagnosed. We describe the first reported case of this interaction.
References
1.
FlorezJ., García SevillaJ.A., BarturenF.[Drugs affecting sympathetic activity]. In: Farmacología Humana.Spain: Masson2008; p. 323–326. Spanish.
2.
AndersonJ.R., DrehsenG., PitmanI.H.Effect of caffeine on ergotamine absorption from rat small intestine.J Pharm Sci1981; 70: 651–657.
3.
Ruano-CalderónL.A., Zermeno-PohlsF.[Ergotism. A case report and review of the literature].Rev Neurol2005; 40: 412–416. Spanish.
4.
Caballero-GranadoF.J., VicianaP., CorderoE., Gomez-VeraM.J., del NozalM., Lopez-CortesL.F.Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient.Antimicrob Agents Chemother1997; 41: 1207.
5.
AvihingsanonA., RamautarsingR.A., SuwanpimolkulG.Ergotism in Thailand caused by increased access to antiretroviral drugs: a global warning.Top Antivir Med2014; 21: 165–168.
DeeksE.D.Cobicistat: a review of its use as a pharmacokinetic enhancer of atazanavir and darunavir in patients with HIV-1 infection.Drugs2014; 74: 195–206.
8.
ShermanE.M., WorleyM.V., UngerN.R., GauthierT.P., SchaferJ.J.Cobicistat: review of a pharmacokinetic enhancer for HIV infection.Clin Ther2015; 37: 1876–1893.
KirklandK.E., KirklandK., ManyW.J.Jr., SmithermanT.A.Headache among patients with HIV disease: prevalence, characteristics, and associations.Headache2012; 52: 455–466.
